Molecular Endocrinology, Vol 7, 1319-1330, Copyright © 1993 by Endocrine Society

ARTICLES

Dominant negative inhibition by mutant thyroid hormone receptors is thyroid hormone response element and receptor isoform specific

AM Zavacki, JW Harney, GA Brent and PR Larsen
Department of Cellular and Developmental Biology, Harvard Medical School, Boston, Massachusetts 02115.

The heterogeneity of tissue-specific manifestations of generalized resistance to thyroid hormone (GRTH) could result from differential interactions between the mutant thyroid hormone (T3) receptor-beta (TR beta) on T3 response elements (TREs) in different T3-responsive genes. To explore this hypothesis, the mutant TR beta associated with kindred A, P448H; a TR beta mutant, P448L; and a comparable TR alpha mutant (P398H) were tested for intrinsic function and for inhibition of wild- type TR alpha- and -beta-induced expression from four structurally distinct TREs, the rGH ABC*, the rGH palindrome (PAL), the rat malic enzyme (ME), and the chicken lysozyme silencer F2 (F2). The relative function of the mutants was similarly reduced on the four TREs studied and was T3 concentration dependent. The TR alpha mutant retained the intrinsically greater potency characteristic of this isoform, but remained impaired with respect to wild-type TR alpha even at 500 nM T3. In general, dominant negative inhibition of wild-type TR alpha and - beta function was dependent upon the T3 concentration, as expected from the decreased affinity for ligand conferred by this mutation. A T3 concentration sufficient to relieve the inhibition of wild-type TR function on the ABC*, PAL, and ME TREs (50 nM) had no effect on inhibition of the F2 TRE by the mutant TRs. Receptor isoform preferential inhibition was observed on the ABC*, PAL, and ME TREs by the mutant TRs. Thus, both TRE structure and the isoform of endogenously active receptor could determine the degree of inhibition of a specific gene in GRTH individuals. Further, the lack of dominant negative potentials does not explain the absence of TR alpha mutations in GRTH kindreds.

This article has been cited by other articles:

				W. Wan, B. Farboud, and M. L. Privalsky Pituitary Resistance to Thyroid Hormone Syndrome Is Associated with T3 Receptor Mutants that Selectively Impair {beta}2 Isoform Function Mol. Endocrinol., June 1, 2005; 19(6): 1529 - 1542. [Abstract] [Full Text] [PDF]

				A. M. Zavacki, H. Ying, M. A. Christoffolete, G. Aerts, E. So, J. W. Harney, S.-y. Cheng, P. R. Larsen, and A. C. Bianco Type 1 Iodothyronine Deiodinase Is a Sensitive Marker of Peripheral Thyroid Status in the Mouse Endocrinology, March 1, 2005; 146(3): 1568 - 1575. [Abstract] [Full Text] [PDF]

				Y.-Y. Liu, J. J. Schultz, and G. A. Brent A Thyroid Hormone Receptor {alpha} Gene Mutation (P398H) Is Associated with Visceral Adiposity and Impaired Catecholamine-stimulated Lipolysis in Mice J. Biol. Chem., October 3, 2003; 278(40): 38913 - 38920. [Abstract] [Full Text] [PDF]

				Y.-Y. Liu, K. H. Tachiki, and G. A. Brent A Targeted Thyroid Hormone Receptor {alpha} Gene Dominant-Negative Mutation (P398H) Selectively Impairs Gene Expression in Differentiated Embryonic Stem Cells Endocrinology, July 1, 2002; 143(7): 2664 - 2672. [Abstract] [Full Text] [PDF]

				G. R. Williams Cloning and Characterization of Two Novel Thyroid Hormone Receptor beta Isoforms Mol. Cell. Biol., November 15, 2000; 20(22): 8329 - 8342. [Abstract] [Full Text]

				J. D. Safer, M. G. O’Connor, S. D. Colan, S. Srinivasan, S. R. Tollin, and F. E. Wondisford The Thyroid Hormone Receptor-{beta} Gene Mutation R383H Is Associated with Isolated Central Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3099 - 3109. [Abstract] [Full Text]

				J. D. Safer, R. N. Cohen, A. N. Hollenberg, and F. E. Wondisford Defective Release of Corepressor by Hinge Mutants of the Thyroid Hormone Receptor Found in Patients with Resistance to Thyroid Hormone J. Biol. Chem., November 13, 1998; 273(46): 30175 - 30182. [Abstract] [Full Text] [PDF]

				T. Tagami and J. L. Jameson Nuclear Corepressors Enhance the Dominant Negative Activity of Mutant Receptors That Cause Resistance to Thyroid Hormone Endocrinology, February 1, 1998; 139(2): 640 - 650. [Abstract] [Full Text] [PDF]

				S. M. Yoh, V. K. K. Chatterjee, and M. L. Privalsky Thyroid Hormone Resistance Syndrome Manifests as an Aberrant Interaction between Mutant T3 Receptors and Transcriptional Corepressors Mol. Endocrinol., April 1, 1997; 11(4): 470 - 480. [Abstract] [Full Text]

				M. Behr, D. B. Ramsden, and U. Loos Deoxyribonucleic Acid Binding and Transcriptional Silencing by a Truncated c-erbA{beta}1 Thyroid Hormone Receptor Identified in a Severely Retarded Patient with Resistance to Thyroid Hormone J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1081 - 1087. [Abstract] [Full Text] [PDF]

				T. N. Collingwood, O. Rajanayagam, M. Adams, R. Wagner, V. Cavailles, E. Kalkhoven, C. Matthews, E. Nystrom, K. Stenlof, G. Lindstedt, et al. A natural transactivation mutation in the thyroid hormone beta  receptor: Impaired interaction with putative transcriptional mediators PNAS, January 7, 1997; 94(1): 248 - 253. [Abstract] [Full Text] [PDF]

				J. D. Safer, M. F. Langlois, R. Cohen, T. Monden, D. John-Hope, J. Madura, A. N. Hollenberg, and F. E. Wondisford Isoform Variable Action among Thyroid Hormone Receptor Mutants Provides Insight into Pituitary Resistance to Thyroid Hormone Mol. Endocrinol., January 1, 1997; 11(1): 16 - 26. [Abstract] [Full Text]

				A. N. Hollenberg, T. Monden, and F. E. Wondisford Ligand-independent and -dependent Functions of Thyroid Hormone Receptor Isoforms Depend upon Their Distinct Amino Termini J. Biol. Chem., June 16, 1995; 270(24): 14274 - 14280. [Abstract] [Full Text] [PDF]

				G. A. Brent The Molecular Basis of Thyroid Hormone Action N. Engl. J. Med., September 29, 1994; 331(13): 847 - 853. [Full Text]